56339-99-2 Usage
Uses
Used in Pharmaceutical Industry:
1-(4-Amino-3-chloro-5-fluoro-phenyl)-ethanone is used as a key intermediate in the synthesis of pharmaceutical drugs for [application reason]. Its unique chemical structure, which includes an aromatic ring with an amino, chloro, and fluoro group, makes it a valuable building block in the development of new medications.
Used in Chemical Research:
In the field of chemical research, 1-(4-Amino-3-chloro-5-fluoro-phenyl)-ethanone is used as a compound for studying the effects of various functional groups on the properties and reactivity of organic molecules. This helps researchers understand the underlying principles governing chemical reactions and can lead to the discovery of new synthetic pathways and applications.
Used in Material Science:
1-(4-Amino-3-chloro-5-fluoro-phenyl)-ethanone may also find applications in material science, where it can be used as a component in the development of novel materials with specific properties. Its unique structure could contribute to the creation of materials with enhanced characteristics, such as improved stability, reactivity, or selectivity in various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 56339-99-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,3,3 and 9 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 56339-99:
(7*5)+(6*6)+(5*3)+(4*3)+(3*9)+(2*9)+(1*9)=152
152 % 10 = 2
So 56339-99-2 is a valid CAS Registry Number.
56339-99-2Relevant academic research and scientific papers
Synthesis of further amino-halogen-substituted phenyl-aminoethanols
Kruger,Keck,Noll,Pieper
, p. 1612 - 1624 (2007/10/02)
Starting from clenbuterol as a lead structure, new 4-amino-phenyl-aminoethanol analogues have been synthesized by different approaches. In these compounds one or both of the chlorine atoms of clenbuterol are replaced by other residues. This has led to compounds with high intrinsic β2-mimetic and/or β1-blocking activities. 1-(4-Amino-3-chloro-5-trifluoromethyl-phenyl)-2-tert.-butylamino-ethanol hydrochloride (mabuterol) has been selected for clinical development. A detailed description is also given of the syntheses of new intermediate acetophenone derivatives as well as of the resolution of mabuterol into its enantiomers.
